Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44204, first published .
Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial

Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial

Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial

Andreas Deckert   1 , PhD ;   Simon Anders   2 , Prof Dr ;   Ivonne Morales   3 , PhD ;   Manuela De Allegri   1 , Prof Dr ;   Hoa Thi Nguyen   1 , PhD ;   Aurélia Souares   1 , PhD ;   Shannon McMahon   1 , PhD ;   Matthias Meurer   2 , Dipl Ing ;   Robin Burk   2 , PhD ;   Dan Lou   2 , PhD ;   Lucia Brugnara   4 , MSc ;   Matthias Sand   5 , PhD ;   Lisa Koeppel   3 , PhD ;   Lena Maier-Hein   6 , Prof Dr ;   Tobias Ross   6 ;   Tim J Adler   6 , PhD ;   Stephan Brenner   1 , PhD ;   Christopher Dyer   7 , PhD ;   Konrad Herbst   2 , PhD ;   Svetlana Ovchinnikova   2 , PhD ;   Michael Marx   4 , Prof Dr ;   Paul Schnitzler   8 , Prof Dr ;   Michael Knop   2 , Prof Dr ;   Till Bärnighausen   1 , Prof Dr ;   Claudia M Denkinger   3 , PD Dr

1 Heidelberg Institute of Global Health, Heidelberg, Germany

2 Center for Molecular Biology Heidelberg, Heidelberg, Germany

3 Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany

4 evaplan GmbH at the University Hospital, Heidelberg, Germany

5 GESIS Leibniz-Institute for the Social Sciences, Mannheim, Germany

6 Division of Computer Assisted Medical Interventions, German Cancer Research Centre, Heidelberg, Germany

7 Gesundheitsamt des Rhein-Neckar-Kreises, Heidelberg, Germany

8 Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany

Corresponding Author: